Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
2019-2023 Europe HIV/AIDS Diagnostics Market: France, Germany, Italy, Spain, UK - Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers
... the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV - 1/2/Combo , HIVAg/HIV NAT , HTLV-I/II, Western Blot and other ... Read More
-
2019-2023 Europe Sexually-Transmitted Diseases (STD) Diagnostics Market: France, Germany, Italy, Spain, UK - Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers
... provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market ... Read More
-
Philippines Pharmaceuticals & Healthcare Q1 2019
... plans to improve access to health services and a growing prevalence of non-communicable diseases among thepopulation. However, the government’s implementation of cost-containment measures and the growing use of generic medicineswill limit opportunities for innovative drugmakers. Read More
-
Thailand Pharmaceuticals & Healthcare Q1 2019
... financial challenges facing the country'suniversal healthcare. Nevertheless, Thailand's long-term story is more positive, and the country will benefit from a number of keypharmaceutical market drivers such as an ageing population and a greater burden of ... Read More
-
United States Pharmaceuticals & Healthcare Q1 2019
... companies, which have been under pressure from PresidentTrump to lower costs for patients. Nevertheless, due to widespread concern among politicians and the public, high drug prices willbe the major issue in the US pharmaceutical market ... Read More
-
Ghana Pharmaceuticals & Healthcare Q1 2019
... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More
-
Marijuana Stores
... The multibillion-dollar global industry is experiencing strong growth, though the newness of the market and variance in regulation across geographies creates major barriers to entry. The industry includes medical marijuana dispensaries and stores that sell ... Read More
-
Biotechnology Product Manufacturing
... Switzerland-based Roche), Gilead Sciences, and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech firms ... Read More
-
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
... well as meet the growing pressure to control costs from consumers, insurance companies and governments has led many biopharmaceutical manufacturers to resort to innovative methods of production. Implementation of process intensification (continuous manufacturing) and use ... Read More
-
Global Human Microbiome Modulators Market: Focus on Non-Dairy Supplements, Drugs, Applications, 15 Countries Data, Pipeline Product Mapping, and Competitive Landscape – Analysis and Forecast, 2018-2023
... is focused on the development of advanced therapeutics to deliver improved patient care and enhance treatment outcome. The increasing prevalence of chronic disorders and an overall increased demand for preventive medication with minimal/no side-effect are ... Read More
-
CAR/TCR Therapies in Oncology: Analytical Tool
... both Novartis and Kite Pharma (now Gilead Sciences) for being the first companies to bring these novel therapies to market with Kymriah (tisagenlecleucel-t) and Yescarta (axicabtagene ciloleucel) respectively. CAR/TCR Therapies in Oncology: Analytical Tool is ... Read More
-
NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
2019-2023 Germany Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and ... Read More
-
2019-2023 UK Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market ... Read More
-
Cancer Vaccines: Analytical Tool
... turbocharged with the event of immune-checkpoint inhibitors. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot and ... Read More
-
Immuno-Oncology Drug Development: Analytical Tool
... current progress of immune-checkpoint inhibitors and CAR-T therapies to make the immune system fight cancer. Immuno-Oncology Drug Development: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who ... Read More
-
Oncolytic Virotherapies: Analytical Tool
... limited clinical efficacy as a single agent and therefore they are often being investigated in the combination with other forms of cancer therapy, including immune checkpoint inhibition. Oncolytic Virotherapies: Analytical Tool is the must have ... Read More
-
Bispecific CD3 Molecules in Oncology: Analytical Tool
... expressed by the T-cell. Upon binding to both targets, these compounds redirect T-cell cytotoxicity toward the malignant cells and effectively eradicate them. Bispecific CD3 Molecules in Oncology: Analytical Tool is the must have handbook for ... Read More
-
Bispecific Molecules in Oncology: Analytical Tool
... tumor-targeted immunomodulators; and (II) dual immunomodulators. Bispecific Molecules in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot ... Read More
-
DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool
... DDR deficiencies to preferentially kill cancer cells, while minimizing the impact on normal cells, has potential for more selective, better tolerated therapies to improve survival in multiple cancers. DNA Damage Response (DDR) Drugs in Oncology: ... Read More
-
Epigenetic Therapies in Oncology: Analytical Tool
... under development and entering clinical trials. Epigenetic Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot ... Read More
-
Immune-checkpoint Drugs in Oncology: Analytical Tool
... changed the possibility to harness the power of the immune system in fighting cancer not only as a monotherapy but, maybe more importantly, also as a combination therapy. Immune-checkpoint Drugs in Oncology: Analytical Tool is ... Read More
-
Protein Kinase Inhibitors in Oncology: Analytical Tool
... genome encoding 538 protein kinases and many of these kinases being associated with human cancer initiation and progression, this field carries a lot of promise for more treatment successes in the future. Protein Kinase Inhibitors ... Read More
